Mechanisms of endothelial dysfunction in rheumatoid arthritis: Lessons from animal studies

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Totoson, Perle ^a   Maguin Gaté, Katy ^a   Prati, Clément ^a,b   Wendling, Daniel ^b   Demougeot, Céline ^a  

^a France   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIRHEUMATIC AGENT; ARGINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; FLUINDOSTATIN; IRBESARTAN; KEISHI BUKURYO GAN; LOSARTAN; NABUMETONE; PROSTANOID; SIMVASTATIN;

ANIMAL MODEL; BLOOD VESSEL REACTIVITY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; EXPERIMENTAL ARTHRITIS; HUMAN; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR DISEASES; VASCULAR ENDOTHELIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; ENDOTHELIUM, VASCULAR; HUMANS; VASCULAR DISEASES;

EID: 84892836822     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4450     Document Type: Review

References (49)

1. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA. The mortality of rheumatoid arthritis. Arthritis Rheum 1994, 37:481-494. 10.1002/art.1780370408, 8147925.
2. van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, Stehouwer CD, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Smulders YM, Dijkmans BA, Nurmohamed MT. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis 2009, 68:1395-1400. 10.1136/ard.2008.094151, 18697775.
3. Peters MJ, van Halm VP, Voskuyl AE, Smulders YM, Boers M, Lems WF, Visser M, Stehouwer CD, Dekker JM, Nijpels G, Heine R, Dijkmans BA, Nurmohamed MT. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum 2009, 61:1571-1579. 10.1002/art.24836, 19877093.
4. Kramer HR, Giles JT. Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity. Arthritis Care Res (Hoboken) 2011, 63:484-499.
5. Mudau M, Genis A, Lochner A, Strijdom H. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr 2012, 23:222-231. 10.5830/CVJA-2011-068, 3721957, 22614668.
6. Bergholm R, Leirisalo-Repo M, Vehkavaara S, Mäkimattila S, Taskinen MR, Yki-Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002, 22:1637-1641. 10.1161/01.ATV.0000033516.73864.4E, 12377742.
7. Sandoo A, van Zanten JJ V, Metsios GS, Carroll D, Kitas GD. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2011, 50:2125-2139.
8. Pearson CM. Development of arthritis, periarthritis and periotitis in rats given adjuvant. Proc Soc Exp Biol Med 1956, 91:95-101. 10.3181/00379727-91-22179, 13297719.
9. Hegen M, Keith JC, Collins M, Nickerson-Nutter CL. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008, 67:1505-1515. 10.1136/ard.2007.076430, 18055474.
10. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, Sakihama T, Matsutani T, Negishi I, Nakatsuru S, Sakaguchi S. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460. 10.1038/nature02119, 14647385.
11. Mensah GA. Healthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease prevention. Vascul Pharmacol 2007, 46:310-314. 10.1016/j.vph.2006.10.013, 17229594.
12. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009, 32:S314-S321. 10.2337/dc09-S330, 2811443, 19875572.
13. Martin BJ, Anderson TJ. Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction. Can J Cardiol 2009, 25:15A-20A. 2787006, 19521569.
14. Fang ZY, Fontaine J, Unger P, Berkenboom G. Alterations of the endothelial function of isolated aortae in rats with adjuvant arthritis. Arch Int Pharmacodyn Ther 1991, 311:122-130.
15. Cinar MG, Can C, Ulker S, Gök S, Coker C, Soykan N, Koşay S, Evinç A. Effect of vitamin E on vascular responses of thoracic aorta in rat experimental arthritis. Gen Pharmacol 1998, 31:149-153. 10.1016/S0306-3623(97)00387-X, 9595294.
16. Ulker S, Onal A, Hatip FB, Sürücü A, Alkanat M, Koşay S, Evinç A. Effect of nabumetone treatment on vascular responses of the thoracic aorta in rat experimental arthritis. Pharmacology 2000, 60:136-142. 10.1159/000028358, 10754450.
17. Can C, Cinar MG, Koşay S, Evinç A. Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration. Life Sci 2002, 71:401-410. 10.1016/S0024-3205(02)01700-9, 12044840.
18. Haruna Y, Morita Y, Komai N, Yada T, Sakuta T, Tomita N, Fox DA, Kashihara N. Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD (P) H oxidase and uncoupled endothelial nitric oxide synthase. Arthritis Rheum 2006, 54:1847-1855. 10.1002/art.21891, 16729278.
19. Haruna Y, Morita Y, Yada T, Satoh M, Fox DA, Kashihara N. Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis. Arthritis Rheum 2007, 56:1827-1835. 10.1002/art.22632, 17530711.
20. Nozaki K, Goto H, Nakagawa T, Hikiami H, Koizumi K, Shibahara N, Shimada Y. Effects of keishibukuryogan on vascular function in adjuvant-induced arthritis rats. Biol Pharm Bull 2007, 30:1042-1047. 10.1248/bpb.30.1042, 17541151.
21. Sakuta T, Morita Y, Satoh M, Fox DA, Kashihara N. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers. Arthritis Rheum 2010, 62:1319-1328. 10.1002/art.27384, 20213806.
22. Prati C, Berthelot A, Wendling D, Demougeot C. Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway. Arthritis Rheum 2011, 63:2309-2317. 10.1002/art.30391, 21484767.
23. Prati C, Berthelot A, Kantelip B, Wendling D, Demougeot C. Treatment with the arginase inhibitor Nw-hydroxy-nor-L-arginine restores endothelial function in rat adjuvant-induced arthritis. Arthritis Res Ther 2012, 14:R130. 3446511, 22647483.
24. Reynolds S, Williams AS, Williams H, Smale S, Stephenson HJ, Amos N, George SJ, O'Donnell VB, Lang D. Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9. Br J Pharmacol 2012, 167:505-514. 10.1111/j.1476-5381.2012.01988.x, 3449256,3449256, 22506619.
25. He M, Liang X, He L, Wen W, Zhao S, Wen L, Liu Y, Shyy JY, Yuan Z. Endothelial dysfunction in rheumatoid arthritis. The role of monocyte chemotactic protein-1-induced protein. Arterioscler Thromb Vasc Biol 2013, 33:1384-1391. 10.1161/ATVBAHA.113.301490, 23580143.
26. Schulz E, Jansen T, Wenzel P, Daiber A, Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008, 10:1115-1126. 10.1089/ars.2007.1989, 18321209.
27. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 2003, 57:456-467. 10.1016/S0008-6363(02)00676-4, 12566118.
28. Pechánová O, Zicha J, Kojsová S, Dobesová Z, Jendeková L, Kunes J. Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension. Clin Sci (Lond) 2006, 110:235-242.
29. Burger D, Touyz RM. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J Am Soc Hypertens 2012, 6:85-99. 10.1016/j.jash.2011.11.003, 22321962.
30. Hua J, Suguro S, Hirano S, Sakamoto K, Nagaoka I. Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats. Inflamm Res 2005, 54:127-132. 10.1007/s00011-004-1333-6, 15883746.
31. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 1998, 273:25804-25808. 10.1074/jbc.273.40.25804, 9748253.
32. Wink DA, Miranda KM, Espey MG, Pluta RM, Hewett SJ, Colton C, Vitek M, Feelisch M, Grisham MB. Mechanisms of the antioxidant effects of nitric oxide. Antioxid Redox Signal 2001, 3:203-213. 10.1089/152308601300185179, 11396476.
33. Bauersachs J, Schäfer A. Tetrahydrobiopterin and eNOS dimer/monomer ratio - a clue to eNOS uncoupling in diabetes?. Cardiovascular Res 2005, 65:768-769.
34. Alp NJ, Channon KM. Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 2004, 24:413-420. 10.1161/01.ATV.0000110785.96039.f6, 14656731.
35. Griendling KK, Sorescu D, Ushio-Fukai M. NAD (P) H oxidase: role in cardiovascular biology and disease. Circ Res 2000, 86:494-501. 10.1161/01.RES.86.5.494, 10720409.
36. Mori M, Gotoh T. Regulation of nitric oxide production by arginine metabolic enzymes. Biochem Biophys Res Commun 2000, 275:715-719. 10.1006/bbrc.2000.3169, 10973788.
37. Morris SM. Recent advances in arginine metabolism: roles and regulation of the arginases. Br J Pharmacol 2009, 157:922-930. 10.1111/j.1476-5381.2009.00278.x, 2737650, 19508396.
38. Ozkor MA, Quyyumi AA. Endothelium-derived hyperpolarizing factor and vascular function. Cardiol Res Pract 2011, 2011:156146. 3157651, 21876822.
39. Feletou M, Vanhoutte PM. Endothelium-derived hyper-polarizing factor: where are we now?. Arterioscler Thromb Vasc Biol 2006, 26:1215-1225. 10.1161/01.ATV.0000217611.81085.c5, 16543495.
40. Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998, 396:269-272. 10.1038/24388, 9834033.
41. Félétou M, Huang Y, Vanhoutte PM. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011, 164:894-912. 10.1111/j.1476-5381.2011.01276.x, 3195913, 21323907.
42. Largo R, Sánchez-Pernaute O, Marcos ME, Moreno-Rubio J, Aparicio C, Granado R, Ortega L, Egido J, Herrero-Beaumont G. Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. Arthritis Rheum 2008, 58:2723-2734. 10.1002/art.23765, 18759289.
43. Félétou M, Verbeuren TJ, Vanhoutte PM. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 2009, 156:563-574. 10.1111/j.1476-5381.2008.00060.x, 2697704, 19154435.
44. Epstein BJ, Leonard PT, Shah NK. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond. Expert Rev Cardiovasc Ther 2012, 10:713-725. 10.1586/erc.12.63, 22894628.
45. der Stoep DF VB-V, Klop B, Van Zeben D, Hazes JM, Castro Cabezas M. Cardiovascular risk in rheumatoid arthritis: how to lower the risk. Atherosclerosis 2013, 231:163-172. 10.1016/j.atherosclerosis.2013.09.006, 24125429.
46. Murdaca G, Colombo BM, Cagnati P, Gulli R, Spanò F, Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 2012, 224:309-317. 10.1016/j.atherosclerosis.2012.05.013, 22673743.
47. Murdaca G, Spano F, Puppo F. Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis. Expert Opin Drug Saf 2013, 12:801-804. 10.1517/14740338.2013.823947, 23889669.
48. Cheung N, Bluemke DA, Klein R, Sharrett AR, Islam FM, Cotch MF, Klein BE, Criqui MH, Wong TY. Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. Am Coll Cardiol 2007, 50:48-55.
49. Struijker-Boudier HA, Rosei AE, Bruneval P, Camici PG, Christ F, Henrion D, Lévy BI, Pries A, Vanoverschelde JL. Evaluation of the microcirculation in hypertension and cardiovascular disease. Eur Heart J 2007, 28:2834-2840. 10.1093/eurheartj/ehm448, 17942581.